Fig. 3From: Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)Long-term survival. a Cumulative incidence of local recurrences; b Disease-free survival and c Overall survival in the intention-to-treat populationBack to article page